You are here: > Home > News > Industry News

News

"DIGITAL PET" THE NATIONAL INNOVATION MEDICAL INSTRUMENT SPECIAL EXAMINATION AND APPROVAL

On January 29th, learned from ezhou that Xie Qingguo lead by professor huazhong university of science and technology research and development of "digitalPET", recently by state food and drug supervision and management of the administration of national innovation medical instrument special examination and approval.This means that the "digital PET" to enterclinicalApplication has open channels, is expected to break the PET market in China was imported high-end medical equipment monopoly situation.

PET, or positron emission tomography imaging, isPrecision medicalThe important equipment, and CT, mri and calledMedical imaging"3 big".Xie Qingguo thinks, "digital PET" principle of scientific innovation, from the source to the performance of the world's leading clinical equipment development, consistent with innovationMedical apparatus and instrumentsAll the requirements.The technology after 18 years of development, with "digital" and "precise sampling" as the characteristic, at the time of cancellation of analog circuit to obtain accurate signal source data, hence the "performance, convenient use, manufacturing fast", such as innovative edge.

For a long time, due to technical threshold is too high for research and development of PET has been western multinationals monopoly, the price is high, become one of the bottlenecks in the field of health care in China.Introduced in ezhou in 2015 "digital PET" as the city's major scientific and technological innovation projects, and set up the industrialization of entity - hubei sharp digital medical imaging technology co., LTD., two years successfully developed the world's first large clinical digital PET/CT, the core indicators of similar products in the international leading in an all-round way.

At present, clinical digital PET/CT clinical evidence of two hospitals in guangzhou has come to an end, at the completion of the state food and drug supervision and administration bureau after further certification of the production on the market.This instrument aoj industrialization chief, said PET into technology more than 40 years, there is no breakthrough progress, has not been solve digital problem, "digital PET" in clinical will be a disruptive impact on traditional PET markets, can be more sensitive to find much earlierThe tumor, the diagnosis of cancer, for the benefit of mankind.


1165374074
johnsonmiaobao